Cargando…
From metagenomic data to personalized in silico microbiotas: predicting dietary supplements for Crohn’s disease
Crohn’s disease (CD) is associated with an ecological imbalance of the intestinal microbiota, consisting of hundreds of species. The underlying complexity as well as individual differences between patients contributes to the difficulty to define a standardized treatment. Computational modeling can s...
Autores principales: | Bauer, Eugen, Thiele, Ines |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068170/ https://www.ncbi.nlm.nih.gov/pubmed/30083388 http://dx.doi.org/10.1038/s41540-018-0063-2 |
Ejemplares similares
-
Arabinoxylan and Pectin Metabolism in Crohn’s Disease Microbiota: An In Silico Study
por: Sabater, Carlos, et al.
Publicado: (2022) -
From Network Analysis to Functional Metabolic Modeling of the Human Gut Microbiota
por: Bauer, Eugen, et al.
Publicado: (2018) -
Integrated Metagenomics/Metaproteomics Reveals Human Host-Microbiota Signatures of Crohn's Disease
por: Erickson, Alison R., et al.
Publicado: (2012) -
Metagenomic Analysis of Saliva Reveals Disease-Associated Microbiotas in Patients With Periodontitis and Crohn’s Disease-Associated Periodontitis
por: Sun, Boyang, et al.
Publicado: (2021) -
Genetic diversity of Escherichia coli in gut microbiota of patients with Crohn’s disease discovered using metagenomic and genomic analyses
por: Tyakht, Alexander V., et al.
Publicado: (2018)